These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 8840936)
21. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives. Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585 [TBL] [Abstract][Full Text] [Related]
22. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Phillips MI Hypertension; 1997 Jan; 29(1 Pt 2):177-87. PubMed ID: 9039099 [TBL] [Abstract][Full Text] [Related]
23. Gene transfer and kidney disease. Imai E; Isaka Y; Akagi Y; Kaneda Y; Hori M J Nephrol; 1998; 11(1):16-9. PubMed ID: 9561480 [TBL] [Abstract][Full Text] [Related]
24. Genetic manipulation of the kidney. Kitamura M; Fine LG Pediatr Nephrol; 1997 Dec; 11(6):773-7. PubMed ID: 9438664 [TBL] [Abstract][Full Text] [Related]
33. Modulation of renal glomerular disease using remote delivery of adenoviral-encoded solubletype II TGF-beta receptor fusion molecule. Haviv YS; Takayama K; Nagi PA; Tousson A; Cook W; Wang M; Lam JT; Naito S; Lei X; Carey DE; Curiel DT J Gene Med; 2003 Oct; 5(10):839-851. PubMed ID: 14533192 [TBL] [Abstract][Full Text] [Related]
34. [Clinical genetics at the crossroads: the example of hereditary kidney diseases]. Grünfeld JP Bull Mem Acad R Med Belg; 2001; 156(10-12):491-6; discussion 496-7. PubMed ID: 12371269 [TBL] [Abstract][Full Text] [Related]
35. Gene therapy for renal diseases. Lien YH; Lai LW Kidney Int Suppl; 1997 Oct; 61():S85-8. PubMed ID: 9328975 [TBL] [Abstract][Full Text] [Related]
36. How will gene therapy apply to the kidney in the 21st century? Kone BC Semin Nephrol; 2000 Jan; 20(1):47-59. PubMed ID: 10651218 [TBL] [Abstract][Full Text] [Related]
37. Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system. Zlokovic BV; Apuzzo ML Neurosurgery; 1997 Apr; 40(4):789-803; discussion 803-4. PubMed ID: 9092853 [TBL] [Abstract][Full Text] [Related]
39. Approaches and methods in gene therapy for kidney disease. van der Wouden EA; Sandovici M; Henning RH; de Zeeuw D; Deelman LE J Pharmacol Toxicol Methods; 2004; 50(1):13-24. PubMed ID: 15233963 [TBL] [Abstract][Full Text] [Related]
40. Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice. Han DC; Hoffman BB; Hong SW; Guo J; Ziyadeh FN Am J Physiol Renal Physiol; 2000 Apr; 278(4):F628-34. PubMed ID: 10751224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]